Clinical Trial Update: Transfusion-Associated Circulatory Overload Best Eliminated With Lasix [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial suggests Lasix (furosemide) may prevent or reduce transfusion-associated circulatory overload.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transfusion-associated Circulatory Overload

Drugs mentioned

• Lasix (furosemide)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Transfusion-associated Circulatory Overload | EARLY_Phase 1 | Status: COMPLETED